Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Eosinophilic esophagitis in children: doubts and future perspectives

Fig. 1

Mechanism of action of monoclonal antibodies for eosinophilic esophagitis (EoE) treatment. ECP eosinophilic cationic protein, EDN eosinophil-derived neurotoxin, IgE immunoglobulin E, FGF fibroblast growth factor, MBP major basic protein, TGF transforming growth factor, Th2 T-helper type 2, TNF tumour necrosis factor, TSLP thymic stromal lymphoprotein

Back to article page